TD Cowen Elevates Twist Bioscience as Top Smidcap Pick, Citing AI-Driven Demand and Margin Leverage
TD Cowen has selected Twist Bioscience (NASDAQ:TWST) as its leading small- to mid-cap idea, pointing to resilient year-to-date performance, exposure to multiple growth drivers including AI-enabled drug discovery, and an underappreciated path to margin expansion as the company scales toward adjusted EBITDA breakeven.